A. Srivastava Et Al. , "Efficacy and safety of a VWF/FVIII concentrate (wilate (R)) in inherited von Willebrand disease patients undergoing surgical procedures," HAEMOPHILIA , vol.23, no.2, pp.264-272, 2017
Srivastava, A. Et Al. 2017. Efficacy and safety of a VWF/FVIII concentrate (wilate (R)) in inherited von Willebrand disease patients undergoing surgical procedures. HAEMOPHILIA , vol.23, no.2 , 264-272.
Srivastava, A., Serban, M., Werner, S., Schwartz, B. A., & Kessler, C. M., (2017). Efficacy and safety of a VWF/FVIII concentrate (wilate (R)) in inherited von Willebrand disease patients undergoing surgical procedures. HAEMOPHILIA , vol.23, no.2, 264-272.
Srivastava, Osman Et Al. "Efficacy and safety of a VWF/FVIII concentrate (wilate (R)) in inherited von Willebrand disease patients undergoing surgical procedures," HAEMOPHILIA , vol.23, no.2, 264-272, 2017
Srivastava, Osman B. Et Al. "Efficacy and safety of a VWF/FVIII concentrate (wilate (R)) in inherited von Willebrand disease patients undergoing surgical procedures." HAEMOPHILIA , vol.23, no.2, pp.264-272, 2017
Srivastava, A. Et Al. (2017) . "Efficacy and safety of a VWF/FVIII concentrate (wilate (R)) in inherited von Willebrand disease patients undergoing surgical procedures." HAEMOPHILIA , vol.23, no.2, pp.264-272.
@article{article, author={Osman Bülent ZÜLFİKAR Et Al. }, title={Efficacy and safety of a VWF/FVIII concentrate (wilate (R)) in inherited von Willebrand disease patients undergoing surgical procedures}, journal={HAEMOPHILIA}, year=2017, pages={264-272} }